Mahmoud Mosli1, Sameer Alawadhi2, Fuad Hasan3, Antoine Abou Rached4, Faisal Sanai5, Silvio Danese6. 1. Gastroenterologist and Inflammatory Bowel Disease Specialist, King Abdulaziz University Hospital, Jeddah, Saudi Arabia. 2. Digestive Disease Unit, Rashid Hospital, Dubai, United Arab Emirates. 3. Department of Medicine, Faculty of Medicine, Kuwait University, Kuwait City, Kuwait. 4. School of Medicine, Lebanese University, Hadath, Lebanon. 5. Department of Medicine, King Abdulaziz University, Jeddah, Saudi Arabia. 6. Professor of Gastroenterology, Faculty of Medicine, Humanitas University, Milan, Italy.
Abstract
OBJECTIVES: Despite the recent findings of the rising incidence of inflammatory bowel disease (IBD) in Arab countries, there are limited data on the characteristics of IBD patients and the disease course in the Arab world. This systematic review aimed to investigate the incidence and epidemiology of IBD in the Arab world. MATERIAL AND METHODS: We conducted a systematic literature review that utilized a comprehensive search of PubMed, Cochrane Central, SCOPUS, Google Scholar, and Web of Science from their inception till August 2020. We included cross-sectional, prospective, and retrospective studies that examined the prevalence and/or epidemiological characteristics of IBD in Arab countries. RESULTS: A total of 16 studies that examined IBD in Saudi Arabia, Egypt, Kuwait, the United Arab Emirates, Bahrain, Lebanon, and Oman were included. Generally, the included studies covered the period from the early 1990s to the late 2010s. A total of 1,627 ulcerative colitis (UC) patients and 1,588 Crohn's disease (CD) patients were included in this systematic review. The mean age at diagnosis ranged from 24.13 to 43.6 years in adult cases and from 4.5 to 16 years in pediatric cases. In most of the included studies, the majority of patients were male. The quantitative analysis revealed a pooled incidence rate of 2.33 (95% confidence interval [CI] 1.2-3.4) per 100,000 persons per year for UC in the Arab world. Likewise, the pooled incidence rate for CD in the Arab world was 1.46 (95% CI 1.03-1.89) per 100,000 persons per year. CONCLUSION: There is a growing incidence of IBD in the Arab world, while IBD patients from Arab countries may present with some different characteristics, compared to their counterparts in Europe.
OBJECTIVES: Despite the recent findings of the rising incidence of inflammatory bowel disease (IBD) in Arab countries, there are limited data on the characteristics of IBD patients and the disease course in the Arab world. This systematic review aimed to investigate the incidence and epidemiology of IBD in the Arab world. MATERIAL AND METHODS: We conducted a systematic literature review that utilized a comprehensive search of PubMed, Cochrane Central, SCOPUS, Google Scholar, and Web of Science from their inception till August 2020. We included cross-sectional, prospective, and retrospective studies that examined the prevalence and/or epidemiological characteristics of IBD in Arab countries. RESULTS: A total of 16 studies that examined IBD in Saudi Arabia, Egypt, Kuwait, the United Arab Emirates, Bahrain, Lebanon, and Oman were included. Generally, the included studies covered the period from the early 1990s to the late 2010s. A total of 1,627 ulcerative colitis (UC) patients and 1,588 Crohn's disease (CD) patients were included in this systematic review. The mean age at diagnosis ranged from 24.13 to 43.6 years in adult cases and from 4.5 to 16 years in pediatric cases. In most of the included studies, the majority of patients were male. The quantitative analysis revealed a pooled incidence rate of 2.33 (95% confidence interval [CI] 1.2-3.4) per 100,000 persons per year for UC in the Arab world. Likewise, the pooled incidence rate for CD in the Arab world was 1.46 (95% CI 1.03-1.89) per 100,000 persons per year. CONCLUSION: There is a growing incidence of IBD in the Arab world, while IBD patients from Arab countries may present with some different characteristics, compared to their counterparts in Europe.
Authors: D F Stroup; J A Berlin; S C Morton; I Olkin; G D Williamson; D Rennie; D Moher; B J Becker; T A Sipe; S B Thacker Journal: JAMA Date: 2000-04-19 Impact factor: 56.272
Authors: Siew C Ng; Whitney Tang; Jessica Y Ching; May Wong; Chung Mo Chow; A J Hui; T C Wong; Vincent K Leung; Steve W Tsang; Hon Ho Yu; Mo Fong Li; Ka Kei Ng; Michael A Kamm; Corrie Studd; Sally Bell; Rupert Leong; H Janaka de Silva; Anuradhani Kasturiratne; M N F Mufeena; Khoon Lin Ling; Choon Jin Ooi; Poh Seng Tan; David Ong; Khean L Goh; Ida Hilmi; Pises Pisespongsa; Sathaporn Manatsathit; Rungsun Rerknimitr; Satimai Aniwan; Yu Fang Wang; Qin Ouyang; Zhirong Zeng; Zhenhua Zhu; Min Hu Chen; Pin Jin Hu; Kaichun Wu; Xin Wang; Marcellus Simadibrata; Murdani Abdullah; Justin Cy Wu; Joseph J Y Sung; Francis K L Chan Journal: Gastroenterology Date: 2013-04-09 Impact factor: 22.682
Authors: Abdulrahman M Aljebreen; Othman R Alharbi; Nahla A Azzam; Ahmed S Almalki; Khalid A Alswat; Majid A Almadi Journal: Saudi J Gastroenterol Date: 2014 May-Jun Impact factor: 2.485
Authors: Amir Mohamed Abdelhamid; Mahmoud E Youssef; Simona Cavalu; Gomaa Mostafa-Hedeab; Amal Youssef; Sara T Elazab; Samar Ibrahim; Shady Allam; Rehab Mohamed Elgharabawy; Eman El-Ahwany; Noha A Amin; Ahmed Shata; Osama A Mohammed; Mahmoud Said Ibrahim Abdeldaiem; Ahmed Alhowail; Gaber El-Saber Batiha; Engy A El-Mahmoudy; Maram Attia; Alaa Allam; Mona Y Zaater; Mona M Osman; Manar Nader; Aya Taha; Nada Abul Makarem; Sameh Saber Journal: Front Pharmacol Date: 2022-06-08 Impact factor: 5.988
Authors: Mohamed Elbadry; Mohamed O Nour; Mohamed Hussien; Elsayed Awad Ghoneem; Mohammed A Medhat; Hany Shehab; Sherif Galal; Mohamed Eltabbakh; Fathiya El-Raey; Mohamed Negm; Shimaa Afify; Walaa Abdelhamed; Ahmed Sherief; Ahmed Abdelaziz; Mohamed Abo Elkasem; Aya Mahrous; Ghada Kamal; Maha Maher; Omar Abdel-Hameed; Abubakr Elbasuny; Islam El-Zayyadi; Ahmed Bassiony; Abdelmajeed Moussa; Essam Bedewy; Asem Elfert; Mohamed El Kassas Journal: Front Med (Lausanne) Date: 2022-04-19